Atomoxetine is a second-line medication treatment option for ADHD. Ghuman, J. K & Hutchison, S. L Evid. Based. Ment. Health, 17(4):108, November, 2014. 00000
Atomoxetine is a second-line medication treatment option for ADHD [link]Paper  doi  abstract   bibtex   
Even though atomoxetine improved both inattentive and hyperactive symptoms, response was lower than for stimulants and 40% of participants taking atomoxetine had significant residual ADHD symptoms. Compared with placebo, a higher proportion of those taking atomoxetine had at least one adverse effect, experienced more weight loss and discontinued study participation.
@article{ghuman_atomoxetine_2014,
	title = {Atomoxetine is a second-line medication treatment option for {ADHD}},
	volume = {17},
	issn = {1362-0347},
	url = {http://dx.doi.org/10.1136/eb-2014-101805},
	doi = {10.1136/eb-2014-101805},
	abstract = {Even though atomoxetine improved both inattentive and hyperactive
symptoms, response was lower than for stimulants and 40\% of participants
taking atomoxetine had significant residual ADHD symptoms. Compared with
placebo, a higher proportion of those taking atomoxetine had at least one
adverse effect, experienced more weight loss and discontinued study
participation.},
	number = {4},
	journal = {Evid. Based. Ment. Health},
	author = {Ghuman, Jaswinder K and Hutchison, Shari L},
	month = nov,
	year = {2014},
	note = {00000},
	keywords = {Sep 20 import, duplicate},
	pages = {108}
}

Downloads: 0